In colon cancer, IL-6 is known to be secreted by stromal fibroblasts, several types of immune cells, and by parenchymal cancer cells to activate STAT3 signaling, thereby mediating tumor-promoting effects [4]. This evidence concerns the gene STAT3 and colonic neoplasm.